Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
Gliomas are one of the most frequent types of nervous system tumours and have significant morbidity and mortality rates. As a result, it is critical to fully comprehend the molecular mechanism of glioma to predict prognosis and target gene therapy. The goal of this research was to discover the hub g...
Main Authors: | Shiao Tong, Minqi Xia, Yang Xu, Qian Sun, Liguo Ye, Jiayang Cai, Zhang Ye, Daofeng Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1000396/full |
Similar Items
-
Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
by: Zhang Ye, et al.
Published: (2022-08-01) -
Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma
by: Shiao Tong, et al.
Published: (2023-02-01) -
A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma
by: Ming-Chun Yang, et al.
Published: (2022-08-01) -
Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
by: Sibin Zhang, et al.
Published: (2022-06-01) -
A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
by: Xiaojiang Peng, et al.
Published: (2023-04-01)